Compare Access Protocol (ACS) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Access Protocol vs Mira — how do they compare? Access Protocol trades at Rp2.23 (market cap Rp114,78M, Rp2,1M 24h volume), while Mira trades at Rp698.38 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: Mira is the larger of the two by market cap, and Mira's supply is capped (321,5M / 1B MIRA (33%)) while Access Protocol's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Access Protocol for 16 Days and Mira for 22 Days on average.
| ACS | MIRA | |
|---|---|---|
Market Cap | Rp114,78M | Rp224,51M |
Volume (24h) | Rp2,1M | Rp102,44M |
Circulating Supply | 51,6B ACS | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 16 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Access Protocol (ACS) is currently trading at Rp2.2343 with a market cap of Rp115.69 million, showing bearish technical signals with moving averages indicating strong selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp2 with similar support levels, suggesting consolidation. No major protocol updates or ecosystem developments have been reported recently, with limited trading activity observed.
Overall outlook remains cautious due to bearish technical indicators and low market cap. Key opportunities include potential accumulation at current levels, while major risks involve low liquidity, high volatility typical of small-cap cryptocurrencies, and limited network activity that could impact price stability.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Access Protocol
Access Protocol provides a new method for digital media publications and content creators to monetize their work. Instead of traditional subscription payments, users stake the ACS token to gain access to premium digital content.
Read more on ACS →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
